State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
ACS Appl Mater Interfaces. 2021 Apr 28;13(16):18533-18544. doi: 10.1021/acsami.1c01730. Epub 2021 Apr 15.
Singlet oxygen (O) plays a vital role in pathophysiological processes and is the dominant executor of photodynamic therapy (PDT). Several small molecular probes have been designed to detect singlet oxygen for the evaluation of PDT efficacy. However, little attention was paid to the precise visualization of the O signal at the subcellular organelle level in living biological systems. Herein, a super-pH-resolved (SPR) nanosensor was developed to specifically illuminate O in endocytic organelles through encoding the cell-impermeant singlet oxygen sensor green (SOSG) into pH-sensitive micelles. The acid-activatable SPR-SOSG achieved more than 10-fold amplification of the O signal, leading to extremely higher sensitivity of singlet oxygen detection in specific endocytic organelles of living cells and animals, as compared with the nonactivatable nanoprobe and the commercially available 2',7'-dichlorofluorescein diacetate (DCFH-DA) probe. Hence, the SPR-SOSG nanoplatform provides a promising tool to evaluate the efficacy and mechanism of nanocarrier-based photodynamic therapy.
单线态氧 (O) 在病理生理过程中起着至关重要的作用,是光动力疗法 (PDT) 的主要执行者。已经设计了几种小分子探针来检测单线态氧,以评估 PDT 的疗效。然而,在活生物系统中,很少关注亚细胞器水平上 O 信号的精确可视化。在此,开发了一种超 pH 分辨 (SPR) 纳米传感器,通过将不透细胞的单线态氧传感器绿 (SOSG) 编码到 pH 敏感胶束中,专门照亮内吞细胞器中的 O。酸激活的 SPR-SOSG 使 O 信号放大了 10 倍以上,与不可激活的纳米探针和市售的 2',7'-二氯荧光素二乙酸酯 (DCFH-DA) 探针相比,在活细胞和动物的特定内吞细胞器中检测到的单线态氧的灵敏度大大提高。因此,SPR-SOSG 纳米平台为评估基于纳米载体的光动力疗法的疗效和机制提供了一种有前途的工具。